Catalyst Wire Dossier Catalyst Wire Dossier
FDA label_change · 2023-10-23

FDA Approved: FULVESTRANT — Supplemental Application (Accord Healthcare Inc.)

View source ↗

Summary

The FDA approved a supplemental application for Fulvestrant from Accord Healthcare Inc., updating the labeling for this generic product.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Fulvestrant (fulvestrant)

Snippet

SUPPL AP for FULVESTRANT (FULVESTRANT)